Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Reuters – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE...